| Hypoxia-driven immune escape in the tumor microenvironment A Vito, N El-Sayes, K Mossman Cells 9 (4), 992, 2020 | 196 | 2020 |
| Tumor heterogeneity: a great barrier in the age of cancer immunotherapy N El-Sayes, A Vito, K Mossman Cancers 13 (4), 806, 2021 | 108 | 2021 |
| A Bone-Seeking trans-Cyclooctene for Pretargeting and Bioorthogonal Chemistry: A Proof of Concept Study Using 99mTc- and 177Lu-Labeled Tetrazines A Yazdani, H Bilton, A Vito, AR Genady, SM Rathmann, Z Ahmad, ... Journal of medicinal chemistry 59 (20), 9381-9389, 2016 | 62 | 2016 |
| Preparation of an 18F‐Labeled Hydrocyanine Dye as a Multimodal Probe for Reactive Oxygen Species S Al‐Karmi, SA Albu, A Vito, N Janzen, S Czorny, L Banevicius, M Nanao, ... Chemistry–A European Journal 23 (2), 254-258, 2017 | 47 | 2017 |
| 125I-Tetrazines and Inverse-Electron-Demand Diels–Alder Chemistry: A Convenient Radioiodination Strategy for Biomolecule Labeling, Screening, and … SA Albu, SA Al-Karmi, A Vito, JPK Dzandzi, A Zlitni, D Beckford-Vera, ... Bioconjugate Chemistry 27 (1), 207-216, 2016 | 42 | 2016 |
| De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors ST Workenhe, A Nguyen, D Bakhshinyan, J Wei, DN Hare, KL MacNeill, ... Communications biology 3 (1), 645, 2020 | 40 | 2020 |
| A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives A Vito, H Alarabi, S Czorny, O Beiraghi, J Kent, N Janzen, AR Genady, ... PloS one 11 (12), e0167425, 2016 | 28 | 2016 |
| Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells A Vito, O Salem, N El-Sayes, IP MacFawn, AL Portillo, K Milne, ... Communications Biology 4 (1), 859, 2021 | 17 | 2021 |
| Combined radionuclide therapy and immunotherapy for treatment of triple negative breast cancer A Vito, S Rathmann, N Mercanti, N El-Sayes, K Mossman, J Valliant International journal of molecular sciences 22 (9), 4843, 2021 | 14 | 2021 |
| A combination of chemotherapy and oncolytic virotherapy sensitizes colorectal adenocarcinoma to immune checkpoint inhibitors in a cDC1-dependent manner N El-Sayes, A Vito, O Salem, ST Workenhe, Y Wan, K Mossman International Journal of Molecular Sciences 23 (3), 1754, 2022 | 13 | 2022 |
| Oncolytic BHV-1 is sufficient to induce immunogenic cell death and synergizes with low-dose chemotherapy to dampen immunosuppressive T regulatory cells ME Davola, O Cormier, A Vito, N El-Sayes, S Collins, O Salem, S Revill, ... Cancers 15 (4), 1295, 2023 | 6 | 2023 |
| IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity N El-Sayes, S Walsh, A Vito, A Reihani, K Ask, Y Wan, K Mossman Molecular Therapy-Oncolytics 25, 16-30, 2022 | 5 | 2022 |
| Synthesis and evaluation of single amino acid chelate (SAAC) tetrazine derivatives for bioorthogonal conjugation with Re/99mTc JF Valliant, R Patel, A Vito Nuclear Medicine and Biology 7 (41), 614-615, 2014 | 3 | 2014 |
| Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy. Cancers 2021, 13, 806 N El-Sayes, A Vito, K Mossman s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 2 | 2021 |
| Genetic modification of oncolytic viruses to enhance antitumor immunity ME Davola, A Vito, J Wei, N El-Sayes, S Workenhe, KL Mossman Methods in Enzymology 635, 231-250, 2020 | 2 | 2020 |
| Correction: A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives A Vito, H Alarabi, S Czorny, O Beiraghi, J Kent, N Janzen, AR Genady, ... Plos one 12 (2), e0171909, 2017 | 2 | 2017 |
| Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer A Vito, N El-Sayes, O Salem, Y Wan, KL Mossman Cancers 13 (21), 5590, 2021 | 1 | 2021 |
| Preparation and evaluation of a single tetrazine-based synthon for labeling biomolecules with both Tc-99m and F-18 AR Vito, H Alarabi, J Kent, J Valliant JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 58, S18-S18, 2015 | 1 | 2015 |
| Investigating Immunotherapy Treatments and the Immunological Synapse in Triple Negative Breast Cancer A Vito | | 2021 |
| Combined radio-and immunotherapy treatments for triple-negative breast cancer A Vito, K Mossman Nuclear Medicine and Biology 72, S22, 2019 | | 2019 |
Karen MossmanProfessor of Pathology and Molecular Medicine, McMaster University在 mcmaster.ca 的电子邮件经过验证
